Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma – benchmark for a prospective multi-institutional study

INTRODUCTION: Several single institution phase I and phase II trials of stereotactic ablative body radiotherapy (SABR) for liver tumors have reported promising results and high local control rates of over 90%. However, there are wide variations in dose and fractionation due to different prescription...

Descripción completa

Detalles Bibliográficos
Autores principales: Eriguchi, Takahisa, Takeda, Atsuya, Oku, Yohei, Ishikura, Satoshi, Kimura, Tomoki, Ozawa, Shuichi, Nakashima, Takeo, Matsuo, Yukinori, Nakamura, Mitsuhiro, Matsumoto, Yasuo, Yamazaki, Sadanori, Sanuki, Naoko, Ito, Yoshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653723/
https://www.ncbi.nlm.nih.gov/pubmed/23641879
http://dx.doi.org/10.1186/1748-717X-8-113

Ejemplares similares

Ejemplares similares